In addition, the composite of cardiovascular death or HF hospitalizations/urgent visits was significantly reduced in patients treated with SGLT2 inhibitors stratified by age, sex, race, renal function, HF functional classification, ejection fraction, and in those with or without diabetes. Here, SLC5A2 is linked to hydrops fetalis.